Lars Muehlenhoff

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study

P. Schirmacher, M. Dietel, Michael Thomas, 2018, BMC Cancer.

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study

P. Schirmacher, M. Dietel, Michael Thomas, 2018, BMC Cancer.